Cargando…
Individualization of antiretroviral therapy - Pharmacogenomic aspect
Combination therapy with three drug regimens for human immunodeficiency virus (HIV) infection significantly suppresses the viral replication. However, this therapeutic impact is restricted by adverse drug events and response in terms of short and long term efficacy. There are multiple factors involv...
Autores principales: | Dalal, Bhavik, Shankarkumar, Aruna, Ghosh, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774063/ https://www.ncbi.nlm.nih.gov/pubmed/26831415 http://dx.doi.org/10.4103/0971-5916.174549 |
Ejemplares similares
-
Human immunodeficiency virus therapeutics and pharmacogenomics
por: Shankarkumar, U., et al.
Publicado: (2011) -
Role of anti-human lymphocyte culture cytotoxic antibodies in recurrent spontaneous pregnancy loss women
por: Umapathy, Shankarkumar, et al.
Publicado: (2011) -
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012) -
Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects
por: Ackenheil, Manfred, et al.
Publicado: (2004) -
HLA involvement in nevirapine-induced dermatological reaction in antiretroviral-treated HIV-1 patients
por: Umapathy, Shankarkumar, et al.
Publicado: (2011)